Lab study uses donated human tissue to speed up drug screening

NCT ID NCT07047677

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study uses leftover tissue from surgeries to test how experimental radiolabeled ligands bind to human cells. Researchers aim to create a platform that can quickly assess these agents without needing animal tests. The study involves 300 tissue samples and focuses on measuring how well the ligands stick to their targets.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this platform could help researchers quickly screen new imaging or therapeutic agents on real human tissue, potentially speeding up drug development.

What could go wrong

This is an early, lab-based study using stored tissue samples, not a treatment trial. Results may not predict how the ligands behave in living patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TISSUE MODEL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chru Nancy

    RECRUITING

    Vandœuvre-lès-Nancy, 54511, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••